Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 - PubMed (original) (raw)
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53
D Michalovitz et al. Cell. 1990.
Abstract
Mutant p53 can contribute to transformation, while wild-type (wt) p53 is not oncogenic and actually inhibits transformation. Furthermore, wt p53 may act as a suppressor gene in human carcinogenesis. We now describe the temperature-sensitive behavior of a particular mutant, p53val135. Like other p53 mutants, it can elicit transformation at 37.5 degrees C. However, at 32.5 degrees C it suppresses transformation, behaving like authentic wt p53. Moreover, the proliferation of transformed cells expressing p53val135 is dramatically inhibited at the permissive temperature. Significantly, the inhibition of both transformation and proliferation is reversible upon temperature upshift. These data demonstrate that the ability of wt p53 to suppress transformation is not due to a general lethal effect, but rather to a reversible growth arrest. p53val135 may prove instrumental for gaining insight into the cellular and molecular properties of wt p53.
Similar articles
- Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M. Eliyahu D, et al. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8763-7. doi: 10.1073/pnas.86.22.8763. Proc Natl Acad Sci U S A. 1989. PMID: 2530586 Free PMC article. - p53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells.
Eliyahu D, Evans S, Rosen N, Eliyahu S, Zwiebel J, Paik S, Lippman M. Eliyahu D, et al. Breast Cancer Res Treat. 1994;30(2):167-77. doi: 10.1007/BF00666061. Breast Cancer Res Treat. 1994. PMID: 7949216 - Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
Martinez J, Georgoff I, Martinez J, Levine AJ. Martinez J, et al. Genes Dev. 1991 Feb;5(2):151-9. doi: 10.1101/gad.5.2.151. Genes Dev. 1991. PMID: 1995413 - The p53 tumor suppressor gene and gene product.
Levine AJ. Levine AJ. Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review. - The oncogenic roles of p53 mutants in mouse models.
Lozano G. Lozano G. Curr Opin Genet Dev. 2007 Feb;17(1):66-70. doi: 10.1016/j.gde.2006.12.003. Epub 2007 Jan 8. Curr Opin Genet Dev. 2007. PMID: 17208429 Review.
Cited by
- Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53.
Marques MA, de Andrade GC, Silva JL, de Oliveira GAP. Marques MA, et al. Front Mol Biosci. 2022 Aug 25;9:944955. doi: 10.3389/fmolb.2022.944955. eCollection 2022. Front Mol Biosci. 2022. PMID: 36090037 Free PMC article. Review. - In vitro responsiveness to serum growth factors is inversely related to in vivo malignancy in human thyroid epithelial cells.
Dawson TP, Wyllie FS, Wynford-Thomas D. Dawson TP, et al. Br J Cancer. 1991 Jun;63(6):897-900. doi: 10.1038/bjc.1991.197. Br J Cancer. 1991. PMID: 2069846 Free PMC article. - Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Moll UM, Riou G, Levine AJ. Moll UM, et al. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262-6. doi: 10.1073/pnas.89.15.7262. Proc Natl Acad Sci U S A. 1992. PMID: 1353891 Free PMC article. - Middle T antigen activation of signal transduction pathways does not overcome p53-mediated growth arrest.
Doherty J, Freund R. Doherty J, et al. J Virol. 1999 Sep;73(9):7882-5. doi: 10.1128/JVI.73.9.7882-7885.1999. J Virol. 1999. PMID: 10438885 Free PMC article. - Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system.
Okazaki T, Sakamuro D. Okazaki T, et al. J Cancer Res Clin Oncol. 2007 Sep;133(9):581-8. doi: 10.1007/s00432-007-0201-5. Epub 2007 May 16. J Cancer Res Clin Oncol. 2007. PMID: 17505842
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous